These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33404163)
1. Roles of metformin-mediated girdin expression in metastasis of epithelial ovarian cancer. Dang J; Gao J; Ma F; Luo Y; Wang J; Wang D; Li W; Sun H; Li L; Liu X; Hu D; Jin Z Cell Biol Int; 2021 May; 45(5):1030-1037. PubMed ID: 33404163 [TBL] [Abstract][Full Text] [Related]
2. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression. Wu W; Gao H; Li X; Zhu Y; Peng S; Yu J; Zhan G; Wang J; Liu N; Guo X Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1. Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838 [TBL] [Abstract][Full Text] [Related]
4. MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway. Pan S; Ren F; Li L; Liu D; Li Y; Wang A; Li W; Dong Y; Guo W Exp Cell Res; 2020 May; 390(1):111939. PubMed ID: 32142853 [TBL] [Abstract][Full Text] [Related]
5. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer. Xu JH; Wang Y; Xu D Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074 [TBL] [Abstract][Full Text] [Related]
6. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma. Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989 [TBL] [Abstract][Full Text] [Related]
7. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells. Lu J; Zhang L; Zhou H; Du Z; Zhang G Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653 [TBL] [Abstract][Full Text] [Related]
8. LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis. Liu S; Xi X Biochem Biophys Res Commun; 2020 Dec; 533(4):1088-1094. PubMed ID: 33036757 [TBL] [Abstract][Full Text] [Related]
9. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression. Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis. Gao H; Li X; Zhan G; Zhu Y; Yu J; Wang J; Li L; Wu W; Liu N; Guo X Cell Cycle; 2019 Jun; 18(12):1393-1406. PubMed ID: 31122127 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment. Mao TL; Fan MH; Dlamini N; Liu CL Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541 [TBL] [Abstract][Full Text] [Related]
12. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway. Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697 [TBL] [Abstract][Full Text] [Related]
13. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells. Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689 [TBL] [Abstract][Full Text] [Related]
14. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway. Zhang C; Li Y; Zhao W; Liu G; Yang Q Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655 [TBL] [Abstract][Full Text] [Related]
15. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945 [TBL] [Abstract][Full Text] [Related]
16. β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway. Wu W; Gao H; Li X; Peng S; Yu J; Liu N; Zhan G; Zhu Y; Wang K; Guo X Cell Cycle; 2019 Jan; 18(1):46-59. PubMed ID: 30582718 [TBL] [Abstract][Full Text] [Related]
17. miR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer. Zhao LG; Wang J; Li J; Li QF Kaohsiung J Med Sci; 2020 Oct; 36(10):799-807. PubMed ID: 32558345 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo. Zeng S; Liu S; Feng J; Gao J; Xue F Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184 [TBL] [Abstract][Full Text] [Related]
19. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition. Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition. Lin X; Tang X; Zheng T; Qiu J; Hua K J Ovarian Res; 2020 Apr; 13(1):45. PubMed ID: 32334623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]